Status:
COMPLETED
Validation of the English Version of the Drug Hypersensitivity Quality of Life Questionnaire
Lead Sponsor:
University Hospitals, Leicester
Conditions:
Drug Hypersensitivity
Quality of Life
Eligibility:
All Genders
18+ years
Brief Summary
We aim to validate the English (UK) translation of the DrHy-Q, and test its reliability in the UK population. This will facilitate for the subsequent economical evaluation of penicillin allergy delabe...
Eligibility Criteria
Inclusion
- • Age \>18 years
- Ability to read English and consent.
- Confirmed diagnosis of a drug hypersensitivity reaction.
- Written informed consent
Exclusion
- • \< 18y/o.
- Not able to read English. No mental capacity to consent or unwilling to consent.
- Unconfirmed diagnosis of a drug hypersensitivity reaction.
Key Trial Info
Start Date :
March 21 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2024
Estimated Enrollment :
146 Patients enrolled
Trial Details
Trial ID
NCT06523192
Start Date
March 21 2023
End Date
May 1 2024
Last Update
July 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UNiversity Hospitals Leicester
Leicester, United Kingdom, LE39QP